Nate Diaz defeated Jorge Masvidal in a boxing match on July 6. Now Diaz has filed a lawsuit in the District Court of USA on Monday, alleging that promoter Solomon Engel and his company Fanmio owe him $9 million. Masvidal and Diaz first faced off each other in 2019 at UFC 244 for the symbolic BMF title, where “Gamebred” won via doctor’s stoppage.
Diaz was promised $9 million after the event
According to ESPN, Diaz claims he had an agreement with Engel and his company to pay him $10 million for the bout against Masvidal, with $1 million to be paid up front and $9 million to be paid after the event. However, the official amount reported by the athletic commission was $500,000. In the lawsuit, Engel has been accused of reneging on the agreement, claiming the event would result in a financial loss. It is unknown how much the fight sold for on PPV, but it was previously reported that the PPV price dropped from $75 to around $25.
The suit describes Engel’s alleged actions, stating that in multiple frustrated phone calls to Diaz’s representatives following the program, Engel pleaded that if they paid Diaz the money he was promised, he would lose more money on the program than he had anticipated and that his wife would divorce him due to the financial losses. Engel even threatened that he would have to declare bankruptcy to avoid paying Nate the money he was owed.
Diaz has sued the company for fraud
Diaz is suing for fraud and breach of contract. “The Stockton Slugger” won the boxing match by majority decision at the Honda Center in Anaheim, California. Nate’s last appearance in the UFC was at UFC 279, where he scored a submission win over Tony Ferguson and then became a free agent. Diaz then moved to boxing and made his professional debut against Jake Paul on August 5, 2023. Despite strong efforts, he lost the bout via unanimous decision. After his win over Masvidal, Diaz expressed his interest in returning to the UFC and also called out Jake Paul for a rematch.
Also Read: Jon Jones charged with two misdemeanors after altercation with drug agent
